Phase I trial of combined recombinant interleukin-2 with levamisole in patients with advanced malignant disease.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/DF648DCD.svg?ark=w1%2F20260515%2FDF648DCD)](https://nobleid.org/work/w1/20260515/DF648DCD)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors